NCT03051087View on ClinicalTrials.gov

To Compare and Evaluate the Efficacy and Safety of Ganilever PFS(Prefilled Syringe) and Orgalutran®

PHASE4CompletedINTERVENTIONAL

Enrollment

255

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

March 31, 2018

Study Completion Date

March 31, 2018

Conditions

Controlled Ovarian Stimulation

Interventions

DRUG

Ganirelix acetate

Trial Locations (2)

Unknown

CHA Bundang Medical Center, CHA University, Gyeonggi-do

CHA Gangnam Medical Center, Seoul

Sponsors

Lead Sponsor

LG Life Sciences

All Listed Sponsors

lead

LG Life Sciences

INDUSTRY

NCT03051087 - To Compare and Evaluate the Efficacy and Safety of Ganilever PFS(Prefilled Syringe) and Orgalutran® | Biotech Hunter | Biotech Hunter